Pullano law firm offers help to Pradaxa victims
Attorneys at the Law Offices of Richard L. Pullano encourage people who suffered side effects after taking the blood-thinning drug Pradaxa to contact the firm for a free legal consultation.
Pradaxa (dabigatran) is a blood-thinning drug that is prescribed to reduce the risk of blood clots and strokes. Recently, serious side effects have come to light that should raise concern for anyone currently taking the medication.
According to CBS News, the “FDA is investigating an unusually large number of reports of serious bleeding linked to the drug.” Reuters news agency reports Pradaxa and a similar drug called Xarelto are raising alarm bells in the medical community:
[G]rowing complaints of risks and deaths tied to the new crop of drugs have made some top U.S. cardiologists hesitant to prescribe them. Some are proposing a more rigorous monitoring regimen for when they are used.
Most concerns revolve around Pradaxa, a twice daily pill from Boehringer Ingelheim that was approved by the U.S. Food and Drug Administration in October 2010 to prevent strokes in patients with an irregular heartbeat called atrial fibrillation. It was the first new oral treatment for that use since warfarin was introduced in the 1950s.
“The good news is you now have an alternative to warfarin,” said Dr. Alan Jacobson, director of anti-coagulation services at the Veterans Administration (VA) healthcare system in Loma Linda, California. “The bad news is you can kill a patient as easily with the new drug as you could with the old drug” if it is not handled properly.
“The average patient doesn’t understand anything about the new drug, or what the risks are, or what other medicines he can or can’t take,” said Jacobson, citing interactions with common painkillers and other drugs that can alter Pradaxa blood levels.
Contact the Law Offices of Richard L. Pullano if you or a loved one has suffered after taking Pradaxa. The firm’s attorneys are experts in product and medical liability lawsuits, and can prosecute potential claims against the manufacturers of this pharmaceutical on your behalf.